the aid library

LIST OPTIONS

Filter

3899

Sort by:

Direction:

Download (208)

View PDF (316)

Training Manual: Climate and Health

International Federation of Medical Students’ Associations (IFMSA) (2016) C1

The project was developed by the International Federation of Medical Students’ Associations (IFMSA), in line with the Federation’s statement “a world in which students are equipped with knowledge, skills and value to take on health leadership roles locally and globally so to... more

Download (317)

View PDF (2669)

Cardiovascular, Respiratory, and Related Disorders. Disease Control Priorities, Third Edition : Volume 5

rabhakaran, Dorairaj; Anand, Shuchi; Gaziano, Thomas A.; et al. World Health Organisation (WHO) (2017) CC

This volume on CVDs, renal, and respiratory disorders has particularly high value. It carries the potential to become the most effective game-changer in global health by helping all countries to combat, contain, and control the biggest killer presently prowling the globe and by enabling us to reach ... more

Download (224)

View PDF (332)

No Time to Wait: Securing the future from drug-resistant infections. Summary of recommendations and key messages

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO

Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues

Download (294)

View PDF (459)

Advancement of the UN CRPD through the 2030 Agenda Towards Implementation in Latin America

International Disability Alliance UNICEF; UN Partnership to Promote Rights of People with Disabilites (2016)

Conference Report Sao Paulo, Brazil 22-24 October 2015

Download (63)

View PDF (81)

Securing the future from drug-resistant infections

Interagency Coordination Group on Antimicrobial Resistance IAGG World Health Organisation WHO (2019) C_WHO

Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous impact within a generation.

Download (205)

View PDF (142)

National Guideline on Clinical Management of Chikungunya Fever

Prof. Dr. S. Tahmina; Prof. Dr. M. S. Flora; Dr. Md. N. A. Khan; Prof. A. K. Saha et al. Government of the People's Republic of Bangladesh DGHS Directorate General of Health Services Ministry of Health and Family Welfare ; World Health Organization (Bangladesh); Disease Control unit (CDC); IEDCR; et al. (2017) C2

Disease Control Division, Standard Management Guideline Directorate General of Health Services, Ministry of Health & Family Welfare First Published: 15th May 2017

Download (99)

View PDF (134)

Medical certification, ICD mortality coding, and reporting mortality associated with COVID-19

World Health Organization WHO (2020) C1

This technical note describes medical certification of cause of death and classification (International Classification of Diseases [ICD] mortality coding) of deaths related to COVID-19. The primary goal is to identify all deaths due to COVID-19 in all countries, including those not yet following WHO... more

Download (93)

View PDF (144)

Exploring the Impact of COVID19 on the Vulnerabilities of Migrants on the Central Mediterranean Route (1 July 2020)

Department for International Development DFID (2020) C1

Download (94)

View PDF (126)

Humanitarian crises monitoring: Coronavirus in developing countries: Secondary impacts

International Development Committee, Government of the United Kingdom (2021) CC

Developing countries face disastrous healthcare setbacks, hunger and huge international debt as covid-19’s ‘final wave’

Download (88)

View PDF (120)

COVID-19 new variants: Knowledge gaps and research

World Health Organization WHO (2021) C_WHO

n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants. The key objectives were to identify the critical research questions related to var... more

Download (81)

View PDF (108)

Social and Economic Impact of COVID-19

E. Levy Yeyati; F. Filippini The Independent Panel (2021) CC

Background paper 13 The Independent Panel for Pandemic Preparedness and Response May 2021

Download (148)

View PDF (189)

Drawing light from the pandemic: A new strategy for health and sustainable development

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Drawing light from the pandemic: A new strategy for health and sustainable development (2021) Available in English, French, German and Russian

Download (70)

View PDF (135)

Alocação justa de recursos de saúde escassos diante da pandemia de COVID-19: considerações éticas

Satomi, E.; P.M. Rodrigues de Souza, B. da Costa Thomé et al. Einstein Journal (2020) CC

As pandemias virais costumam representar sérias ameaças ao equilíbrio dos sistemas de saúde, ao impor-lhes demandas extraor-dinárias e sustentadas, que podem ultrapassar a capacidade de atendimento, no que diz respeito tanto aos insumos e às tecnologias disponíveis, quanto aos recurs... more

Download (87)

View PDF (1028)

Pollution and health: a progress update
recommended

Fuller, R.; et al. (2022) CC

The Lancet Planetary Health Published:May 17, 2022DOI:https://doi.org/10.1016/S2542-5196(22)00090-0 Every year pollution causes 9 million deaths—1 in every 6 deaths worldwide, according to a Lancet Commission on pollution and health. While the number of deaths caused by household air pollution a... more

Download (121)

View PDF (124)

Note d’orientation de l’OMS sur la COVID-19 : Instaurer la confiance grâce à la communication sur les risques et à la participation communautaire

Organisation Mondiale de la Santé OMS (2022) C_WHO

Les notes d’orientation décrivent les mesures essentielles que les décideurs aux niveaux national et infranational peuvent mettre en place concernant les aspects suivants : les tests de diagnostic de la COVID19, la prise en charge clinique de la COVID-19, la réalisation des cibles en matière ... more

Download (149)

View PDF (188)

Global patient safety action plan 2021–2030: towards eliminating avoidable harm in health care

World Health Organisation (WHO) (2022) C_WHO

Today, patient harm due to unsafe care is a large and growing global public health challenge and is one of the leading causes of death and disability worldwide. Most of this patient harm is avoidable. As countries strive to achieve universal health coverage and the Sustainable Development Goals, t... more

Download (105)

View PDF (93)

Global Trends and Prospects

United Nations Conference on Trade and Development (2023) CC

According to most recent data, the world economy grew by 3.1 per cent in 2022. To many, the rebound suggested that a soft landing was possible in 2023, and that the key problems of the year 2022 – rising prices, supply-chain disruptions and recession risks – have been addressed. As a result, t... more

Download (31)

View PDF (26)

From emergency response to long-term COVID-19 disease management - Ending the COVID-19 emergency and transitioning from emergency phase to longer-term disease management: Guidance on calibrating the r

World Health Organization WHO (2023) C_WHO

The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows: National action plan key activities, prioritized for the current context and the current ... more

Download (100)

View PDF (101)

Break COVID Now: The Gavi COVAX AMC Investment Opportunity

Gavi, the Vaccine Alliance (2022) CC

In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si... more

Download (7)

View PDF (6)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Pollution and health: a progress update recommended

Pollution and health: a progress update
recommended